While both compounds work through distinct biological pathways, combining them demands personalized medical evaluation and monitoring to prevent adverse effects and ensure therapeutic benefit
Slower digestion can also affect how often weight fluctuations show up from week to week
Arie Blitz, MD, MBA, a cardiac surgeon and health policy commentator
Weight loss outcomes with GLP-1 therapy depend on many individual factors, including starting weight, metabolism, adherence to the program, and lifestyle habits
In this episode of All-In, Eli Lilly CEO Dave Ricks discusses his company's development of GLP-1 drugs, which began with an unexpected discovery during diabetes treatment research and led to the creation of Monjaro
Privacy Policy